Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Upadacitinib may effectively treat resistant lichen planopilaris.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Tofacitinib may effectively treat folliculitis decalvans.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Fzd2 is important for skin and hair development through various signaling ways.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.